| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,329 | 715 | 905 | 808 | | Cost of Revenue |
-
| (901) | 901 | 3,123 | | | Gross Profit | 1,329 | 1,616 | 4 | (2,315) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 848 | 1,894 | 120 | (2,350) | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 418 | (278) | (116) | 35 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,805) | (6,110) | 1,090 | (15,803) | | Earnings Before Interest And Taxes | (7,354) | (5,298) | (116) | 3,181 | | Interest Expense | 11 | 11 | 11 | 29 | | Income Before Tax | (7,365) | (5,309) | (127) | 3,152 | | Income Tax Expense | 30 |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,395) | (6,399) | 963 | (15,797) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,365) | (6,399) | 963 | (15,797) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,365) | ($6,399) | $963 | ($15,797) |
|
0.31% Nasdaq 0.00%
Income Statement
